InspireMD, Inc. Series B Warrants
NSPRZ
NSPRZ was delisted on the 14th of March, 2022.
4 hedge funds and large institutions have $42K invested in InspireMD, Inc. Series B Warrants in 2018 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
33% less capital invested
Capital invested by funds: $63K → $42K (-$21K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.12K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$129 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AFM
1
Anson Funds Management
Dallas,
Texas
| $40K | – | – | – |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $2K | -$1.12K | -415,503 | -22% |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$129 | -47,696 | -32% |
|
NSPRZ Hedge Fund Activity: Q4 2018 in Review
4 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q4 2018, worth a combined $42K — down 33% from $63K a quarter earlier.
Fund positioning in NSPRZ was balanced in Q4 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Sabby Management, cutting an estimated $1.12K.
- 4 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $42K of InspireMD, Inc. Series B Warrants stock for Q4 2018, down 33% quarter-over-quarter.
- 0 funds opened new InspireMD, Inc. Series B Warrants positions in Q4 2018 and 0 closed out.
- The largest InspireMD, Inc. Series B Warrants seller in Q4 2018 was Sabby Management, an estimated $1.12K sold.
Based on aggregated 13F filings for Q4 2018.